Evidence map›Paper›PMID 40575216›Full record

ReviewCureus2025

Clenbuterol Abuse in Bodybuilding and Athletics: Unsupervised Use, Psychological Motivations, and Health Consequences.

Suhas Kataveni, Raga Priya Gourishetty, Shruti M Mundada, Moksha Prasoona Avvaru, Vijay S Kollipara, Sai Pranay Gottimukkala

Abstract readReview
In one paragraph

Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Suhas KataveniInternal Medicine, Gandhi Medical College and Hospital, Hyderabad, IND.
Raga Priya GourishettyInternal Medicine, Gandhi Medical College and Hospital, Hyderabad, IND.
Shruti M MundadaInternal Medicine, Gandhi Medical College and Hospital, Hyderabad, IND.
Moksha Prasoona AvvaruInternal Medicine, Gandhi Medical College and Hospital, Hyderabad, IND.
Vijay S KolliparaInternal Medicine, Gandhi Medical College and Hospital, Hyderabad, IND.
Sai Pranay GottimukkalaGeneral Medicine, Srikara Hospitals, Hyderabad, IND.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Clenbuterol is a β2-adrenergic agonist originally developed as a bronchodilator but is now often used without supervision for its perceived muscle-building and fat-burning effects. Although it is not approved for human use in many regions, it continues to be used in bodybuilding and athletics for physique and performance enhancement. Its appeal lies in its ability to influence muscle development and fat metabolism. Many individuals use it due to psychological motivators such as body image concerns and a desire for rapid physical changes. However, its use may result in side effects involving the heart, muscles, and overall physical well-being, such as arrhythmias, hypertension, and muscle spasms. In some cases, it has also been linked to accidental exposure through contaminated food. The widespread misuse of clenbuterol raises ethical concerns in competitive environments. More discussion is needed around developing safer methods of achieving similar goals, and there is a need for increased public awareness and caution regarding its use.

Indexed as

anabolic agentsathletesbodybuildingclenbuteroldopingperformance-enhancing drugsβ2-adrenergic agonist

Identifiers

PMID40575216
PMCPMC12200009

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.